News

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
In mid-April 2025, social media users spread a rumor that U.S. President Donald Trump's administration would end animal ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The U.S. Food and Drug Administration (FDA) has announced an ambitious effort to modernize drug testing by reducing reliance ...